Billionaire investor Icahn targets Biogen Idec again
Billionaire activist investor Carl Icahn is continuing to put pressure on Cambridge biotechnology giant Biogen Idec.
For the second year in a row, Icahn nominated several directors to sit on Biogen Idec's board. This year, he nominated directors to fill four of the board's 13 slots, the company announced this morning.
If successful, the slots would give Icahn a powerful platform to push for changes in the company, including a possible sale of the firm.
Boston Globe article